As of November 6, 2026, 3 holders' latest Schedule 13D or 13G filings report owning 5% or more of Apyx Medical Corp. The largest reported stake is Nantahala Capital Management, LLC's, at 9.99%. 4 filings are on record since January 20, 2026 (Schedule 13G/A, February 13, 2026).
Sell to companies like Apyx Medical Corp? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
Key facts
- · Reporting person: Philotimo Fund, LP · Sole voting: 0 · Shared voting: 1,425,473 · Sole dispositive: 0 · Shared dispositive: 1,425,473 · SCHEDULE 13G, 2026-10-28
- · Reporting person: Royce & Associates LP · Sole voting: 3,274,064 · Shared voting: 0 · Sole dispositive: 3,274,064 · Shared dispositive: 0 · SCHEDULE 13G/A, 2026-07-21
- · Reporting person: Nantahala Capital Management, LLC · Sole voting: 0 · Shared voting: 4,112,705 · Sole dispositive: 0 · Shared dispositive: 4,112,705 · SCHEDULE 13G/A, 2026-02-13
- · Holder: Royce & Associates LP · Percent: 5.95% · SCHEDULE 13G/A
Apyx Medical Corp has 4 Schedule 13D or 13G filings on record since 2026-01-20. 3 holders' latest filing reports 5% or more of common stock, $0.001 par value per share. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| Nantahala Capital Management, LLC | 9.99% | 4,112,705 | SCHEDULE 13G/A, 2026-02-13 | 2025-12-31 |
| Royce & Associates LP | 7.81% | 3,274,064 | SCHEDULE 13G/A, 2026-07-21 | 2026-06-30 |
| Kanen Wealth Management LLC | 5.4% | 2,280,518 | SCHEDULE 13G, 2026-10-28 | 2026-10-21 |
Holding shares or following this stake? See who's behind Apyx Medical Corp and the warning signs.
Free to see. No signup.
Keep reading
More on Apyx Medical Corp and the records around it.
Apyx Medical Corp elsewhere on the record
Companies that share a holder
- Philotimo Fund, LP also filed stake reports on 9 other companies: Fossil Group, Inc. (Sep 2026), Allot Ltd. (Jun 2026), Lovesac Co (May 2026)
- ROYCE & ASSOCIATES LP also filed stake reports on 61 other companies: Aetherion Technoligies Inc. (Oct 2026), Andersen Group Inc (Oct 2026), NN, Inc. (Oct 2026)
- Nantahala Capital Management, LLC also filed stake reports on 70 other companies: Research Alliance Corp III (Oct 2026), ADC Therapeutics SA (Aug 2026), Anteris Technologies Global Corp. (Aug 2026)
Watch Apyx Medical Corp
Get an email when Apyx Medical Corp files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
Want the whole picture on Apyx Medical Corp?
Example from a real report (our sample on Target): “The Q2 2026 earnings report, published August 19, 2026, showed adjusted EPS of $2.46 against an expected $2.33” Source: CNBC
A Full Report on Apyx Medical Corp: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on Apyx Medical Corp covers
The Short Answer
Which Company This Is
What They Do, And How The Money Works
Who Runs It, And How To Reach Them
The Money: Funding, Valuation, Runway
Who Pays Them, And Who They Are Up Against
Warning Bells
Sources
4 cited sources found
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
Voting and dispositive power, as filed
| Reporting person | Sole voting | Shared voting | Sole dispositive | Shared dispositive | Filing |
|---|---|---|---|---|---|
| Nantahala Capital Management, LLC | 0 | 4,112,705 | 0 | 4,112,705 | SCHEDULE 13G/A, 2026-02-13 |
| Wilmot B. Harkey | 0 | 4,112,705 | 0 | 4,112,705 | SCHEDULE 13G/A, 2026-02-13 |
| Daniel Mack | 0 | 4,112,705 | 0 | 4,112,705 | SCHEDULE 13G/A, 2026-02-13 |
| Royce & Associates LP | 3,274,064 | 0 | 3,274,064 | 0 | SCHEDULE 13G/A, 2026-07-21 |
| Philotimo Fund, LP | 0 | 1,425,473 | 0 | 1,425,473 | SCHEDULE 13G, 2026-10-28 |
| Philotimo Focused Growth & Income Fund | 0 | 855,045 | 0 | 855,045 | SCHEDULE 13G, 2026-10-28 |
| Kanen Wealth Management LLC | 0 | 2,280,518 | 0 | 2,280,518 | SCHEDULE 13G, 2026-10-28 |
| Kanen David | 0 | 2,280,518 | 0 | 2,280,518 | SCHEDULE 13G, 2026-10-28 |
The latest filing identifies Apyx Medical Corp by CUSIP 03837C106 and gives its principal executive office as 5115 ULMERTON ROAD, CLEARWATER, FL 33760 (SCHEDULE 13G, 2026-10-28).
What the percentages are based on
The aggregate percentage of the Shares reported owned by each person named herein is based upon 42,124,023 Shares outstanding as of August 5, 2026, which is the total number of Shares outstanding as reported in the Issuer's Form 10-Q filed with the Securities and Exchange Commission on August 6, 2026.Kanen Wealth Management LLC, SCHEDULE 13G, 2026-10-28
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2026-01-20 | Royce & Associates LP | 5.95% | SCHEDULE 13G/A |
| 2026-02-13 | Nantahala Capital Management, LLC | 9.99% | SCHEDULE 13G/A |
| 2026-07-21 | Royce & Associates LP | 7.81% | SCHEDULE 13G/A |
| 2026-10-28 | Kanen Wealth Management LLC | 5.4% | SCHEDULE 13G |
Questions about who owns Apyx Medical Corp
Who owns Apyx Medical Corp?
On this page, 3 holders' latest ownership filings report 5% or more of Apyx Medical Corp: Nantahala Capital Management, LLC (9.99%, Schedule 13G/A, filed 2026-02-13), Royce & Associates LP (7.81%, Schedule 13G/A, filed 2026-07-21) and Kanen Wealth Management LLC (5.4%, Schedule 13G, filed 2026-10-28).
Who are the largest shareholders of Apyx Medical Corp?
By the share each holder's latest filing reports, the largest holders of Apyx Medical Corp on this page are Nantahala Capital Management, LLC (9.99%), Royce & Associates LP (7.81%) and Kanen Wealth Management LLC (5.4%).
When did Nantahala Capital Management, LLC buy into Apyx Medical Corp?
The filings give report dates, not purchase dates. The earliest filing from Nantahala Capital Management, LLC on this page is the Schedule 13G/A, filed 2026-02-13, reporting 9.99%. That earliest filing is itself an amendment, which updates an earlier report.
Is this an audit or a full list?
Neither. The ownership list on this page covers only Schedule 13D and 13G filings, which holders make once they own 5% or more of a class of shares (an amendment can report a stake that has since fallen below 5%); 4 such filings are shown here. It is not an audit and not a full cap table: holders who never reached 5% are not listed, and a stake can change after its latest filing.
Tools for this story
Each opens in a new tab, filled in for Apyx Medical Corp. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.